| __timestamp | AbbVie Inc. | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 2854000000 |
| Thursday, January 1, 2015 | 4285000000 | 3014000000 |
| Friday, January 1, 2016 | 4366000000 | 5098000000 |
| Sunday, January 1, 2017 | 4982000000 | 3734000000 |
| Monday, January 1, 2018 | 10329000000 | 5018000000 |
| Tuesday, January 1, 2019 | 6407000000 | 9106000000 |
| Wednesday, January 1, 2020 | 6557000000 | 5039000000 |
| Friday, January 1, 2021 | 7084000000 | 5363000000 |
| Saturday, January 1, 2022 | 6510000000 | 4977000000 |
| Sunday, January 1, 2023 | 8453000000 | 6923000000 |
Unleashing the power of data
In the competitive landscape of biotechnology, innovation is key. Over the past decade, AbbVie Inc. and Gilead Sciences, Inc. have been at the forefront, investing heavily in research and development (R&D) to drive breakthroughs. From 2014 to 2023, AbbVie consistently outpaced Gilead in R&D spending, with a notable peak in 2018 when AbbVie's investment surged by over 130% compared to 2014. Gilead, while trailing, showed a significant 142% increase in 2019, highlighting its commitment to innovation. By 2023, AbbVie's R&D expenses were approximately 22% higher than Gilead's, underscoring its strategic focus on pioneering new treatments. This trend reflects the broader industry emphasis on innovation as a catalyst for growth and competitiveness. As these giants continue to invest, the future of healthcare looks promising, with potential breakthroughs on the horizon.
R&D Spending Showdown: AbbVie Inc. vs Alnylam Pharmaceuticals, Inc.
Analyzing R&D Budgets: AbbVie Inc. vs Madrigal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: AbbVie Inc. vs Rhythm Pharmaceuticals, Inc.
AbbVie Inc. or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: AbbVie Inc. and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Geron Corporation
Gilead Sciences, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Gilead Sciences, Inc. vs Dr. Reddy's Laboratories Limited
Gilead Sciences, Inc. vs BioMarin Pharmaceutical Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Mesoblast Limited
Research and Development: Comparing Key Metrics for Gilead Sciences, Inc. and Taro Pharmaceutical Industries Ltd.